| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.2M | -1.1% |
| R&D Expense | $150.4M | +48.6% |
| SG&A Expense | $37.7M | +44.0% |
| Operating Income | -$178.9M | -51.6% |
| Interest Expense | $0 | — |
| Income Tax | $0 | — |
| Net Income | -$174.0M | -47.4% |
| EPS (Basic) | -$3.34 | -17.2% |
| EPS (Diluted) | -$3.34 | -17.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $340.4M | +6.2% |
| Current Assets | $622.9M | +51.5% |
| Total Assets | $638.8M | +49.4% |
| Current Liabilities | $51.9M | +75.0% |
| Total Liabilities | $60.7M | +31.6% |
| Stockholders' Equity | $578.1M | +51.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$136.3M | -43.7% |
| Capital Expenditures | $2.8M | -24.5% |
| Investing Cash Flow | -$190.0M | -130.2% |
| Financing Cash Flow | $346.2M | +96.3% |
| Free Cash Flow | -$139.1M | -41.1% |